Literature DB >> 730363

Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

T W Chang, S L Gorbach, J B Bartlett.   

Abstract

Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxin was studied by cytotoxicity assay in tissue culture. The sources of toxin were stools from two patients with pseudomembranous colitis and a culture filtrate of C. difficile isolated from one of the patients. C. sordellii antitoxin was available either in monovalent form or as gas gangrene polyvalent antitoxin. The potency of antitoxins against C. difficile determined by cytotoxicity assay did not correlate with the established values reported for mouse protection tests against C. sordellii toxin. An equivalent zone of optimal neutralization was demonstrated for stool toxin, and a slightly different one for culture toxin. The rate of neutralization appeared to be instantaneous, either at 24 or at 37 degrees C. The efficacy of antitoxin in preventing cytotoxicity in cultured cells preexposed to toxin decreased rapidly with preexposure time. The union between toxin and antitoxin could be readily dissociated by simple dilution or by ammonium sulfate precipitation followed by dissociated by simple dilution or by ammonium sulfate precipitation followed by dilution. Continued incubation of toxin-antitoxin mixture did not increase the firmness of the union; on the contrary, more dissociation occurred. The unusual looseness of the toxin-antitoxin union is probably relatd to lack of serological specificity or affinity. Based on these observations, a practical diagnostic method for antibiotic-induced colitis is outlined.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730363      PMCID: PMC422172          DOI: 10.1128/iai.22.2.418-422.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Comparison of five regimens for treatment of experimental clindamycin-associated colitis.

Authors:  J G Bartlett; T W Chang; A B Onderdonk
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

2.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

3.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients.

Authors:  T W Chang; J G Bartlett; S L Gorbach; A B Onderdonk
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

5.  Aetiology of antimicrobial-agent-associated colitis.

Authors:  W L George; V L Sutter; E J Goldstein; S L Ludwig; S M Finegold
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

6.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

7.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

  7 in total
  27 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.

Authors:  Catherine Eckert; Eleonore Holscher; Amandine Petit; Valérie Lalande; Frédéric Barbut
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

3.  Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.

Authors:  M Y Dong; T W Chang; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.

Authors:  F Barbut; M Monot; A Rousseau; S Cavelot; T Simon; B Burghoffer; V Lalande; J Tankovic; J-C Petit; B Dupuy; C Eckert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-13       Impact factor: 3.267

5.  Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.

Authors:  P C De Girolami; P A Hanff; K Eichelberger; L Longhi; H Teresa; J Pratt; A Cheng; J M Letourneau; G M Thorne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Etiology of tetracycline-associated pseudomembranous colitis in hamsters.

Authors:  R Toshniwal; R Fekety; J Silva
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.

Authors:  M T Kelly; S G Champagne; C H Sherlock; M A Noble; H J Freeman; J A Smith
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

9.  Criteria for detection of Clostridium difficile toxin production by counterimmunoelectrophoresis.

Authors:  R P Rennie; J M Elliott; M A Nardini; J H Thornley
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

10.  Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study.

Authors:  P L Stark; A Lee; B D Parsonage
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.